Thomas Tu - Mar 28, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role: Chief Medical Officer
Signature: /s/ Angela Ahmad, attorney-in-fact for Thomas Tu
Stock symbol: NARI
Transactions as of: Mar 28, 2022
Transactions value $: -$180,000
Form type: 4
Date filed: 3/30/2022, 04:33 PM
Previous filing: Mar 2, 2022
Next filing: Apr 5, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$914	+2K	+2.56%	$0.46	80.3K	Mar 28, 2022	Direct	F1
transaction	NARI	Common Stock	Sale	-$180K	-2K	-2.48%	$90.00	78.5K	Mar 28, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Option	Options Exercise	-$914	-2K	-0.99%	$0.46	200K	Mar 28, 2022	Common Stock	2K	$0.46	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2	Includes 225 shares acquired under the Employee Stock Purchase Plan.
F3	Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.